Helsinn About Us
We are a global pharmaceutical company and a leader in supportive care focused on improving the health and quality of life of patients with cancer and chronic diseases.
Learn more
We have always been driven by the desire to improve the lives of cancer patients, guided by core values of integrity, passion and quality.
Learn moreA Comprehensive Technical Organization
Our technical organization orchestrates a balanced mix of internal and external capabilities, covering multiple aspect from development and regulatory affairs, to manufacturing and supply chain.
Beyond routine production at our state-of-the-art manufacturing plant in Ireland, we thrive in new product development starting from deep internal know-how and extensive cross-functional collaborations, seamlessly transforming strategic thoughts into real brands and evolutions thereof.
The partner of choice
We build, launch and commercialize solid brands globally with a strong focus in supportive care, able to reach patients worldwide through our extensive commercial and supply network, leveraging our integrated platform based on broad technical expertise.
Learn moreCommitted to responsible business growth
We believe building the trust of stakeholders through maximizing positive societal impact will, in turn, make Helsinn more sustainable. Prioritizing the well-being of patients and society creates a virtuous cycle, strengthening our reputation, fostering collaboration, and driving innovation.
Sustainability
Over the years, Helsinn has remained committed to running a responsible and sustainable business by delivering high quality products to patients, whilst reducing and improving our impact on the environment and society. Sustainability has always been one of the main drivers in our corporate culture and has become a crucial element of our strategic vision.
Carbon Neutral Company
For the third year we have achieved carbon neutrality. We have progressed on our path towards a reduction of our greenhouse gas footprint and the remaining emissions have been offset through the purchase of Gold Standard certificates.
Ethics and Governance
We always strive to go further and bring better todays to even more and more patients. Our ethical reputation are the key ingredients to deliver this ambitious promise to patients and gain their trust. It is therefore vital that we hold ourselves to the highest ethical standards across our entire business, above and beyond what is required.
Read our news and insights
Helsinn Group announces AKYNZEO® (fosnetupitant/palonosetron) injection is now available in a ready-to-use vial in the US
Learn moreHelsinn Group announces AKYNZEO® (fosnetupitant/palonosetron) injection is now available in a ready-to-use vial in the US
Learn morePartnership with Immedica for commercialisation of cancer supportive car
Helsinn and Immedica enter exclusive partnership for commercialisation of cancer supportive care products in core European markets
Learn moreHelsinn closes financing agreement with Oberland Capital
Helsinn Group, a fully integrated, global biopharma company with a track record of over forty years of commercial execution and a strong focus in oncology and rare diseases announced a financing agreement with Oberland Capital Management LLC
Learn moreDr. Melanie Rolli - Group Chief Executive Officer
Helsinn Group announced the appointment of the Group’s current Chief Operating Officer, Dr Melanie Rolli as Group Chief Executive Officer (“CEO”) effective from January 1st, 2023.
Learn morePhase 3 trial in patients with CINV
Helsinn Group announced results from a secondary analysis of the Phase 3 multicenter pivotal trial in patients with breakthrough chemotherapy-induced nausea and vomiting (CINV) receiving antiemetic prophylaxis (oral or IV NEPA)
Learn more